Prevalence of Helicobacter pylori infection in gastroesophageal reflux disease and Barrett's esophagus

Medicina Clinica

Volumn 119, Issue 6, 2002, Pages 217-223

  Gisbert, Javier P ^a   Pajares, José María ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Barrett's esophagus; Epidemiology; Gastroesophageal reflux disease; Helicobacter pylori; Prevalence

Indexed keywords

UREASE;

BARRETT ESOPHAGUS; CONTROLLED STUDY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INTERNET; MEDLINE; PREVALENCE; REVIEW; RISK ASSESSMENT; ARTICLE; CLINICAL TRIAL; ISOLATION AND PURIFICATION; META ANALYSIS; MICROBIOLOGY;

BARRETT ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PREVALENCE;

EID: 0037072151     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(02)73368-x     Document Type: Review

References (98)

1. Clinical epidemiology and natural history of gastroesophageal reflux disease
2. Usefulness of anti-Helicobacter pylori and anti-CagA antibodies in the selection of patients for gastroscopy
3. Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2.253 dyspeptic patients
4. The prevalence of esophagitis in patients with duodenal ulcer or ulcer-like dyspepsia
5. The association of histologic gastritis with gastroesophageal reflux and delayed gastric emptying
6. Helicobacter pylori and gastroesophageal reflux disease: Friends or foes?
7. The only good Helicobacter pylori is a dead Helicobacter pylori
8. Helicobacter pylori infection is associated with milder gastro-oesophageal reflux disease
9. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma
10. Helicobacter pylori and gastro-oesophageal reflux disease -a prospective study
11. Esophagitis and Helicobacter pylori in children: Incidence and therapeutic implications
12. Treatment of ulcerative reflux oesophagitis with colloidal bismuth subcitrate in combination with cimetidine
13. Helicobacter pylori in 205 consecutive endoscopy patients Scand
14. Helicobacter pylori: Has it a part in the lesion of the gastroesophageal reflux?
15. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
16. Non-steroidal anti-inflammatory drugs, hiatus hernia, and Helicobacter pylori, in patients with oesophageal ulceration
17. Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis
18. ¿Existe alguna relación entre la infección por Helicobacter pylori y la esofagitis péptica?
19. Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease
20. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis
21. Dysfunction of oesophageal motility in Helicobacter pylori-infected patients with reflux oesophagitis
22. Helicobacter pylori infection correlates with severity of reflux esophagitis: With manometry findings
23. Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus
24. Fundal gastritis as a potential cause of reflux oesophagitis
25. Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: Case-control study in Japan
26. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion
27. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: Analysis of 5,732 Japanese subjects
28. The significance of cagA(+) Helicobacter pylori in reflux oesophagitis
29. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis
30. Helicobacter pylori infection, pattern of gastritis, and symptoms in erosive and nonerosive gastroesophageal reflux disease
31. Reflux oesophagitis and Helicobacter pylori infection in elderly patients
32. Prevalence of Campylobacter pylori in esophagitis, gastritis, and duodenal disease
33. Prevalence of Helicobacter pylori infection in patients with reflux oesophagitis
34. Gastric mucosal atrophy and prevalence of Helicobacter pylori in reflux esophagitis of the elderly
35. Reflux esophagitis patients in Singapore have motor and acid exposure abnormalities similar to patients in the Western hemisphere
36. The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis: A case-control study
37. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: A study from the East
38. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease
39. Helicobacter pylori and gastroesophageal reflux disease: Lack of influence of infection on twenty-four-hour esophageal pH monitoring and endoscopic findings
40. Corpus gastritis is protective against reflux oesophagitis
41. Gastroesophageal reflux disease: Prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms
42. Colonization with cagA-positive Helicobacter pylori strains inversely associated with reflux esophagitis and Barrett's esophagus
43. Inflammation and intestinal metaplasia of the gastric cardia: The role of gastroesophageal reflux and H. pylori infection
44. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus
45. Campylobacter-like organisms and Candida in peptic ulcers and similar lesions of the upper gastrointestinal tract: A study of 247 cases
46. The prevalence of Helicobacter pylori infection and the pattern of gastritis in Barrett's esophagus
47. Helicobacter pylori infection in patients with Barrett's oesophagus: A prospective immunohistochemical study
48. Gruppo Operativo per lo Studio delle Precancerosi Esofagee (GOSPE)-Precancerous Lesions of the Oesophagus Task Force, Italy
49. Incidencia de Helicobacter pylori en el esófago de Barrett
50. Campylobacter pylori and Barrett's esophagus
51. Prevalence and significance of Helicobacter pylori in patients with Barrett's esophagus
52. Barrett's esophagus and the presence of Helicobacter pylori
53. Helicobacter pylori in Barrett's esophagus
54. Helicobacter pylori in Barrett's esophagus and in normal or inflamed esophageal mucosa: A retrospective study
55. Heterotopic gastric mucosa in the upper esophagus: A prospective study of 33 cases and review of literature
56. Barrett's oesophagus and Helicobacter pylori
57. Helicobacter pylori en el esófago de Barrett
58. Gastric and esophageal Campylobacter pylori in patients with Barrett's esophagus
59. Organismos de tipo Campylobacter en el esófago de Barrett
60. Patterns of colonisation of Campylobacter pylori in the oesophagus, stomach and duodenum
61. Helicobacter pylori colonization of Barrett's esophagus and its progression to cancer
62. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma
63. Rising incidence of adenocarcinoma of the esophagus and gastric cardia
64. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction
65. Adenocarcinoma in Barrett's esophagus: A new epidemic?
66. Epidemiology of columnar-lined esophagus and adenocarcinoma
67. Opposing time trends of peptic ulcer and reflux disease
68. Helicobacter pylori in Hispanics: Comparison with blacks and whites of similar age and socioeconomic class
69. Severity of Helicobacter-induced gastric injury correlates with gastric juice ammonia
70. Long-term sequelae of Helicobacter pylori gastritis
71. Antral atrophy, Helicobacter pylori colonization, and gastric pH
72. Interaction of Helicobacter pylori and its fatty acids with parietal cells and gastric H+/K(+)-ATPase
73. Effect of a Campylobacter pylori protein on acid secretion by parietal cells
74. Infección por Helicobacter pylori y concentraciones basales de gastrina sérica en pacientes con úlcera duodenal y en individuos con endoscopia normal
75. Effect of human gastrin-17 with and without acid suppression on human esophageal motility
76. Helicobacter pylori: Un mismo germen, distintas enfermedades
77. Gastric acid secretion and pattern of gastroesophageal reflux in patients with esophagitis and concomitant duodenal ulcer. A multivariate analysis of pathogenetic factors
78. pylori and cagA: Eelationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications
79. Helicobacter pylori is not associated with the manifestations of gastroesophageal reflux disease
80. Campylobacter pylori and reflux oesophagitis
81. Recurrent abdominal pain of gastro-intestinal origin
82. Esófago de Barrett en niños. Presentación de 12 casos
83. The increasing frequency of adenocarcinoma of the esophagus
84. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
85. Rising incidence of oesophageal adenocarcinoma in men in Australia
86. Esophageal and gastric carcinoma in Norway 1958-1992: Incidence time trend variability according to morphological subtypes and organ subsites
87. Relation between gastric cancer and previous peptic ulcer disease
88. Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study
89. An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma
90. Helicobacter pylori infection is associated with a decreased risk of developing oesophageal neoplasms
91. Helicobacter pylori-associated antibodies in patients with duodenal ulcer, gastric and oesophageal adenocarcinoma
92. Lack of association of Helicobacter pylori infection and adenocarcinoma arising in Barrett's esophagus
93. Serological response to specific Helicobacter pylori antigens: Antibody against CagA antigen is not predictive of gastric cancer in a developing country
94. The incidence of reflux esophagitis among the Chinese
95. Helicobacter pylori and atrophic gastritis: Importance of the cagA status
96. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach
97. Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology